The just-approved booster is intended for people originally vaccinated with shots made by Pfizer and its partner BioNTech.
The CDC on Thursday endorsed Pfizer COVID-19 vaccine booster shots for millions of older or otherwise vulnerable Americans.
Millions of Americans are now eligible to receive a Pfizer booster shot to help increase their protection against the worst effects of the coronavirus.
Healthcare workers have continued to risk their own lives to save others, which is why the Houston Methodist CEO called a federal advisory panel vote not to approve booster shots for them a slap in the face. However, on Friday morning the CDC's director overruled that decision.
President Joe Biden is urging those now eligible for COVID-19 booster shots to get the added protection.
The delta variant has been identified in at least 180 countries, according to the World Health Organization.
A CDC panel continued to discuss specific recommendations on Pfizer’s COVID-19 booster following the FDA’s sign-off for certain Americans.
The FDA has approved Pfizer’s COVID-19 vaccine booster for those who are 65 years and up or run a high risk of severe disease, according to reports.
“Don’t get vaccinated” was the simple message painted on a box truck driven around Charlotte that appeared to promote a local funeral home. But the funeral home doesn’t exist, and the message instead was promoting the vaccine.
The CDC’s Advisory Committee on Immunization Practices is meeting this week to review data on Pfizer’s booster dose and who should get it.
President Joe Biden announced that the U.S. is doubling its purchase of Pfizer's COVID-19 shots to share with the world to 1 billion doses.
Months after a grand jury declined to indict him, Dr. Hasan Gokal has filed a lawsuit against Harris County, alleging discrimination "based on his race and national origin."
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
Johnson & Johnson’s booster was found to be 94% effective against symptomatic COVID-19 in the U.S. two months after the first shot, the company said.
Pfizer said its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
At a time when nurses are leaving the field, a local university is looking to help meet the needs through an accelerated nursing degree program. A graduate of that nursing program is switching careers to work on the front line of the battle.
An independent advisory panel for the FDA voted against a proposal for a booster dose of Pfizer-BioNTech’s COVID-19 vaccine for Americans 16 and older.
"We understand that COVID-19 is a very real health concern that we all have to take seriously," said event organizer Nick Caturano, "but many cast members have a legitimate basis for refusing vaccination."
Karl Bohnak began working at WLUC in Marquette in 1988. He says the Upper Peninsula was one of the most challenging places in the U.S. for weather forecasting.
You might not be as protected as you think with the COVID-19 shot, which is why there’s a debate on whether a booster is needed now.